Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK", you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you. If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Goodwin Procter.

Goodwin Doubles Down On Antitrust, M&A With Another Partner Hire (Reuters)

Related Content

DOJ Sues Private Equity Firm KKR & Co. for Violations of HSR Act

Massachusetts Passes Comprehensive Revisions to Healthcare Transaction Notification Law with Significant Implications for Private Equity Healthcare Investments

2025 HSR Thresholds Announced: $126.4 million

Business Groups File Lawsuit Challenging HSR Rule Changes

FTC and DOJ Finalize Major Changes to HSR Form and Disclosure Requirements

The General Court of the European Union Annuls a €1.5 Billion Fine Against Google AdSense

FTC Escalates Battle Against PBMs With Complaint on Insulin Pricing

Antitrust & Competition Healthcare Quarterly Update Q2 2024

Goodwin Expands Global Antitrust and EU Regulatory Footprint with New Brussels Office and Adds Top Competition Law Expert Stephen Mavroghenis

GCR 100 2025 Names Goodwin an Elite Firm for Antitrust Law

Goodwin Releases Update to its Comprehensive Guide to Biosimilars Litigation and Regulation in the U.S.

Brightcove To Be Acquired By Bending Spoons For $233 Million

Goodwin advises Investor Consortium on Series B Financing of The Exploration Company

BlueHalo To Be Acquired By AeroVironment In $4.1 Billion All-Stock Transaction

AlloVir and Kalaris Therapeutics to Merge

Best Lawyers Best Law Firms 2025 Names Goodwin Biotechnology and Life Sciences Law Firm of the Year for the Eighth Time and Recognizes 55 Practice Areas

Technology

Life Sciences

Private Equity

Medtech

Antitrust & Competition

Mergers & Acquisitions

Complex Litigation & Dispute Resolution

Antitrust Services for Life Sciences Companies

Litigation